India's Thyrocare jumps on Phillip Capital initiation with 'Buy'

Thyrocare Technologies

06/01/2026 08:15

** Shares of Thyrocare Technologies THYO.NS rise 4.8% to 484.3 rupees; set for fourth straight session of gains

** Phillip Capital initiates coverage on the healthcare services provider with "Buy" rating and Street-high PT of 640 rupees, an implied upside of 38.6% over Monday's close

** Brokerage says Thyrocare’s flexible approach to onboard standalone labs, clinics, and hospitals positions it as one of India’s most structurally consistent, fastest growing platforms in diagnostics

** Expects co's new initiatives such as ECG bundling with Aarogyam packages, premium sub-brands such as Jaanch and Her Check and targeted packages for GLP-1 users to drive value-led growth

** Brokerage estimates co will see annual compunded growth rate of 14% in its franchise network to 13,000 in FY28; also sees annual compunded growth rate of 18% in franchise revenues

** Stock rose 46.6% in 2025

 (Reporting by Mridula Kumar in Bengaluru)

 ((Mridula.Kumar@thomsonreuters.com;))